| |
| |
|
| Insider
Information: |
Dockendorff Charles J |
| Relationship: |
Director |
| City: |
Mansfield |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
5 |
|
| Direct
Shares |
59,453 |
|
|
Indirect Shares
|
93,287 |
|
|
| Direct
Value |
$8,131,275 |
|
|
|
Indirect Value
|
$7,254,868 |
|
|
| Total
Shares |
152,740 |
|
|
| Total
Value |
$15,386,143 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
2
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
2
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
-2.0
|
| Percentage
Gain/Loss : |
0.0%
|
 -74.3%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Covidien Plc |
COV |
EVP & Chief Financial ... |
2015-01-26 |
0 |
2015-01-26 |
0 |
Premium* |
|
|
Haemonetics Corp |
HAE |
Director |
2023-09-05 |
2,226 |
2023-09-05 |
17,915 |
Premium* |
|
|
Keysight Technologies Inc |
KEYS |
Director |
2024-03-22 |
52,754 |
2023-01-06 |
0 |
Premium* |
|
|
Boston Scientific Corp |
BSX |
Director |
2024-05-09 |
2,901 |
2024-05-09 |
60,002 |
Premium* |
|
|
Hologic Inc |
HOLX |
Director |
2024-03-08 |
1,572 |
2024-03-08 |
15,370 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
143 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 4 of 6
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| COV |
Covidien Plc |
EVP & Chief Financial Officer |
• – – |
2008-07-02 |
4 |
D |
$48.64 |
$236,950 |
D/D |
(4,872) |
80,142 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
Director |
• • – |
2022-05-05 |
4 |
A |
$0.00 |
$0 |
D/D |
4,877 |
17,079 |
0 |
- |
|
| COV |
Covidien Plc |
EVP & Chief Financial Officer |
• • – |
2013-12-01 |
4 |
D |
$68.26 |
$338,501 |
D/D |
(4,959) |
106,314 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
Director |
– • – |
2019-05-09 |
4 |
A |
$0.00 |
$0 |
D/D |
4,990 |
11,099 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
Director |
• • – |
2020-05-07 |
4 |
A |
$0.00 |
$0 |
D/D |
5,000 |
16,099 |
0 |
- |
|
| COV |
Covidien Plc |
EVP & Chief Financial Officer |
• – – |
2011-07-02 |
4 |
D |
$54.22 |
$287,529 |
D/D |
(5,303) |
102,425 |
0 |
- |
|
| COV |
Covidien Plc |
EVP & Chief Financial Officer |
• – – |
2010-08-04 |
4 |
B |
$37.24 |
$204,813 |
D/D |
5,500 |
98,339 |
2.74 |
- |
|
| COV |
Covidien Plc |
EVP & Chief Financial Officer |
• – – |
2008-01-11 |
4 |
A |
$0.00 |
$0 |
D/D |
5,613 |
87,098 |
0 |
- |
|
| COV |
Covidien Plc |
EVP & Chief Financial Officer |
• • – |
2012-12-01 |
4 |
D |
$58.11 |
$338,084 |
D/D |
(5,818) |
127,532 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
Director |
• • – |
2018-05-10 |
4 |
A |
$0.00 |
$0 |
D/D |
6,109 |
63,213 |
0 |
- |
|
| KEYS |
Keysight Technologies Inc |
Director |
• • – |
2018-03-23 |
4 |
A |
$0.00 |
$0 |
D/D |
6,626 |
58,425 |
0 |
- |
|
| COV |
Covidien Plc |
EVP & Chief Financial Officer |
• • – |
2013-12-02 |
4/A |
A |
$0.00 |
$0 |
D/D |
6,757 |
113,071 |
0 |
- |
|
| COV |
Covidien Plc |
EVP & Chief Financial Officer |
• – – |
2009-11-10 |
4 |
AS |
$45.00 |
$306,000 |
D/D |
(6,800) |
88,956 |
0 |
- |
|
| COV |
Covidien Plc |
EVP & Chief Financial Officer |
• – – |
2009-11-10 |
4 |
OE |
$18.20 |
$123,772 |
D/D |
6,800 |
95,756 |
0 |
- |
|
| COV |
Covidien Plc |
EVP & Chief Financial Officer |
• – – |
2011-10-06 |
4 |
D |
$44.12 |
$305,575 |
D/D |
(6,926) |
112,220 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
Director |
• • – |
2017-05-09 |
4 |
A |
$0.00 |
$0 |
D/D |
7,012 |
57,104 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
Director |
• • – |
2021-05-06 |
4 |
A |
$0.00 |
$0 |
D/D |
7,202 |
39,501 |
0 |
- |
|
| KEYS |
Keysight Technologies Inc |
Director |
– • – |
2022-12-12 |
4 |
GD |
$0.00 |
$0 |
D/D |
7,551 |
55,680 |
0 |
- |
|
| HOLX |
Hologic Inc |
Director |
• • – |
2024-01-02 |
4 |
OE |
$38.44 |
$290,260 |
D/D |
7,551 |
17,482 |
0 |
- |
|
| KEYS |
Keysight Technologies Inc |
Director |
• • – |
2017-03-17 |
4 |
A |
$39.02 |
$301,859 |
D/D |
7,736 |
38,590 |
0 |
- |
|
| COV |
Covidien Plc |
EVP & Chief Financial Officer |
• • – |
2012-12-03 |
4 |
A |
$0.00 |
$0 |
D/D |
7,921 |
135,453 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
Director |
• • – |
2023-01-06 |
4 |
GD |
$0.00 |
$0 |
I/I |
8,201 |
0 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
Director |
• • – |
2016-05-03 |
4 |
A |
$0.00 |
$0 |
D/D |
8,494 |
50,092 |
0 |
- |
|
| KEYS |
Keysight Technologies Inc |
Director |
– • – |
2014-11-05 |
4 |
A |
$0.00 |
$0 |
D/D |
8,766 |
8,766 |
0 |
- |
|
| HAE |
Haemonetics Corp |
Director |
• • – |
2023-09-05 |
4 |
AS |
$87.68 |
$895,651 |
D/D |
(10,215) |
2,226 |
0 |
% |
|
143 Records found
|
|
Page 4 of 6 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
